Literature DB >> 2608880

Vasculitis complicating cystic fibrosis.

M J Finnegan1, J Hinchcliffe, D Russell-Jones, S Neill, E Sheffield, D Jayne, A Wise, M E Hodson.   

Abstract

Twelve patients with skin vasculitis complicating cystic fibrosis are described. Seven of these were proven histologically and of these two had systemic vascultitis. Staining of vasculitic tissue by the avidin-biotin immunoperoxidase technique using both monoclonal and polyclonal antisera directed against Haemophilus influenzae, staphylococcus aureus and Pseudomonas aeruginosa did not consistently reveal any bacterial antigens in these tissues. In one patient the vasculitis appeared secondary to ranitidine. There was no evidence of autoimmune disease in any of the patients. Antineutrophil cytoplasmic antibodies were detected in the serum of 40 per cent of the patients with vasculitis complicating cystic fibrosis but in none of 61 controls with cystic fibrosis (but without vasculitis) matched for age and sex and with similar bacteriological flora of sputum.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2608880

Source DB:  PubMed          Journal:  Q J Med        ISSN: 0033-5622


  12 in total

1.  Vasculitis and arthropathy in cystic fibrosis.

Authors:  M E Hodson
Journal:  J R Soc Med       Date:  1992       Impact factor: 5.344

2.  Peripheral nerve dysfunction in adult patients with cystic fibrosis.

Authors:  J I O'Riordan; J Hayes; M X Fitzgerald; J Redmond
Journal:  Ir J Med Sci       Date:  1995 Jul-Sep       Impact factor: 1.568

Review 3.  Pulmonary vasculitis.

Authors:  A Burns
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

Review 4.  ANCA-associated diseases and silica exposure.

Authors:  G Gregorini; P Tira; J Frizza; P C D'Haese; M M Elseviers; G Nuyts; R Maiorca; M E De Broe
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

Review 5.  Joint disorders in cystic fibrosis.

Authors:  M A Turner; E Baildam; L Patel; T J David
Journal:  J R Soc Med       Date:  1997       Impact factor: 5.344

Review 6.  Chronic suppurative lung disease with associated vasculitis.

Authors:  I N Bruce; J A McAteer; P V Gardiner; R J McFarland; J M Sloan; A L Bell
Journal:  Postgrad Med J       Date:  1995-01       Impact factor: 2.401

7.  Anti-neutrophil cytoplasmic antibodies (ANCA) against bactericidal/permeability-increasing protein (BPI) and cystic fibrosis lung disease.

Authors:  R Mahadeva; A C Dunn; R C Westerbeek; L Sharples; D B Whitehouse; N R Carroll; R I Ross-Russell; A K Webb; D Bilton; D A Lomas; C M Lockwood
Journal:  Clin Exp Immunol       Date:  1999-09       Impact factor: 4.330

8.  Detection of antineutrophil cytoplasmic antibody in a patient with L-tryptophan induced eosinophilia-myalgia syndrome.

Authors:  A M Cilursu; J Goeken; R R Olson
Journal:  Ann Rheum Dis       Date:  1991-11       Impact factor: 19.103

Review 9.  ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.

Authors:  W L Gross; W H Schmitt; E Csernok
Journal:  Clin Exp Immunol       Date:  1993-01       Impact factor: 4.330

10.  Recurrent vasculitis in cystic fibrosis.

Authors:  Lareina Wujanto; Clare Ross
Journal:  BMJ Case Rep       Date:  2010-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.